Dr. Scott V. Dindot, an associate professor in the College of Veterinary Medicine & Biomedical Sciences’ (CVM) Department of Veterinary Pathobiology (VTPB), is one of three faculty members from across the Texas A&M campus to be recognized with a 2019 Innovation Award.
The award, presented during the Texas A&M Technology Commercialization’s (TTC) annual Patent and Innovation Awards Luncheon on April 18, acknowledges researchers whose work exemplifies the spirit of innovation within The Texas A&M University System.
“I am truly honored by this award and am grateful for the opportunity to pursue this area of research at Texas A&M University,” Dindot said.
Dindot, who also holds a joint appointment with the Texas A&M College of Medicine, works with a specific gene implicated in a rare disorder, Angelman syndrome, and has developed a targeted drug therapy—antisense oligonucleotide—that may provide a solution.
He has filed two patent applications for this innovation and has licensed his innovations to GeneTx Biotherapies LLC.
He received his doctorate in genetics from Texas A&M, working under the guidance of Dr. Jorge Piedrahita, and completed postdoctoral training in genetics and epigenetics as a National Institutes of Health (NIH) fellow at Baylor College of Medicine.
During the luncheon, TTC also presented four patent plaques to Dr. Luc Berghman, who holds a joint appointment as a professor in the VTPP department and in the College of Agriculture & Life Sciences, for his work on vaccine vectors and immunological responses.
In total, 49 Patent Awards were presented to 53 faculty members and other researchers from the A&M System whose inventions received protection from the U.S. Patent and Trademark Office during 2018.
“The process of developing and patenting our innovations is integral to how Texas A&M University approaches its mission as a land-grant research institution,” said Vice President for Research Mark A. Barteau said. “First, patents serve the public by providing a clear path for innovations to move from the laboratory to the marketplace. Second, they provide important revenue streams for the A&M System and our researchers. Third, for every dollar we receive from these revenue streams, we generate $1.40 in research reinvestments.”
Contact Information: Jennifer Gauntt, Interim Director of CVM Communications, Texas A&M College of Veterinary Medicine & Biomedical Science; email@example.com; 979-862-4216